Foliglurax monohydrochloride
≥98%
- Product Code: 60227
CAS:
2133294-96-7
| Molecular Weight: | 457.97 g./mol | Molecular Formula: | C₂₃H₂₄ClN₃O₃S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
Foliglurax monohydrochloride is primarily investigated for its potential therapeutic applications in neurological disorders. It acts as a positive allosteric modulator of the metabotropic glutamate receptor 4 (mGluR4), which plays a role in regulating neurotransmitter release and synaptic plasticity. This mechanism makes it a promising candidate for treating conditions such as Parkinson’s disease, where mGluR4 modulation can help alleviate motor symptoms by enhancing dopamine signaling and reducing excitotoxicity. Additionally, its neuroprotective properties are being explored for potential use in other neurodegenerative diseases, offering hope for slowing disease progression and improving patient outcomes. Research is ongoing to fully understand its efficacy and safety in clinical settings.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿46,170.00 |
+
-
|
| 0.010 | 10-20 days | ฿76,950.00 |
+
-
|
Foliglurax monohydrochloride
Foliglurax monohydrochloride is primarily investigated for its potential therapeutic applications in neurological disorders. It acts as a positive allosteric modulator of the metabotropic glutamate receptor 4 (mGluR4), which plays a role in regulating neurotransmitter release and synaptic plasticity. This mechanism makes it a promising candidate for treating conditions such as Parkinson’s disease, where mGluR4 modulation can help alleviate motor symptoms by enhancing dopamine signaling and reducing excitotoxicity. Additionally, its neuroprotective properties are being explored for potential use in other neurodegenerative diseases, offering hope for slowing disease progression and improving patient outcomes. Research is ongoing to fully understand its efficacy and safety in clinical settings.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :